Log in to save to my catalogue

Tumor necrosis factor-alpha, prostaglandin-E2 and interleukin-1β targeted anti-arthritic potential o...

Tumor necrosis factor-alpha, prostaglandin-E2 and interleukin-1β targeted anti-arthritic potential o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2887604964

Tumor necrosis factor-alpha, prostaglandin-E2 and interleukin-1β targeted anti-arthritic potential of fluvoxamine: drug repurposing

About this item

Full title

Tumor necrosis factor-alpha, prostaglandin-E2 and interleukin-1β targeted anti-arthritic potential of fluvoxamine: drug repurposing

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Environmental science and pollution research international, 2023-02, Vol.30 (6), p.14580-14591

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Fluvoxamine, a selective serotonin re uptake inhibitor, is used to treat depression. The aim of present study was to evaluate fluvoxamine in acute (egg albumin-induced inflammation) and chronic inflammatory rat models (formaldehyde and complete Freund’s adjuvant (CFA)-induced arthritis). Fluvoxamine showed highly significant (
p
<0.001) prote...

Alternative Titles

Full title

Tumor necrosis factor-alpha, prostaglandin-E2 and interleukin-1β targeted anti-arthritic potential of fluvoxamine: drug repurposing

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2887604964

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2887604964

Other Identifiers

ISSN

1614-7499

E-ISSN

1614-7499

DOI

10.1007/s11356-022-23142-1

How to access this item